Omada Health, Inc. Stock-Based Compensation
Omada Health, Inc. (OMDA) reported Stock-Based Compensation of $9.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- Omada Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $5.63M, a 98.98% increase year-over-year.
- Omada Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.21M, a 48.00% increase year-over-year.
- Omada Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.75M, a 61.98% increase year-over-year.
- Omada Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.54M, a 63.70% increase year-over-year.
- Omada Health, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $12.96M, a 37.53% increase from fiscal 2024.
- Omada Health, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $9.42M, a 7.78% increase from fiscal 2023.
- Omada Health, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $8.74M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $9.84M 10-Q · filed 2026-08-07 | $13.59M derived: sum of 3 quarters · filed 2026-08-07 | $17.12M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $4.21M 10-Q · filed 2026-05-08 | $7.95M derived: sum of 2 quarters · filed 2026-05-08 | $11.49M derived: sum of 3 quarters · filed 2026-05-08 | $14.32M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $7.28M derived: sum of 2 quarters · filed 2026-03-06 | $10.11M derived: sum of 3 quarters · filed 2026-08-07 | $12.96M 10-K · filed 2026-03-06 |
| 2025-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $6.37M derived: sum of 2 quarters · filed 2026-08-07 | $9.21M 10-Q · filed 2025-11-07 | $11.52M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.67M 10-Q · filed 2026-08-07 | $7.99M derived: sum of 3 quarters · filed 2026-08-07 | $10.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.84M 10-Q · filed 2026-05-08 | $5.16M derived: sum of 2 quarters · filed 2026-05-08 | $7.32M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $4.47M derived: sum of 2 quarters · filed 2026-03-06 | $9.42M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $7.11M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $4.95M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $8.74M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |